Neurologic and metabolic phenotypes in an AL amyloidosis transgenic mouse model

被引：0
|
作者：
Ward, J. E. [3 ,4 ]
SooHoo, P. [1 ,4 ]
Tordaldo, G. [3 ]
Jasuja, R. [3 ]
Connors, L. H. [2 ,4 ]
O'Hara, C. [1 ,4 ]
Seldin, D. C. [3 ,4 ]
机构：
[1] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA
[3] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
[4] Boston Univ, Sch Med, Gerry Amyloid Res Lab, Boston, MA 02118 USA
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2010年 / 17卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：115 / 115
页数：1
相关论文
共 50 条
  • [1] Metabolic phenotype in an AL amyloidosis transgenic mouse model
    Ward, J. E.
    SooHoo, P.
    Toraldo, G.
    Jasuja, R.
    Connors, L. H.
    O'Hara, C.
    Seldin, D. C.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2011, 18 : 40 - 41
  • [2] A Transgenic Mouse Model of Cardiac AL Amyloidosis
    Martinez-Rivas, Gemma
    Ayala, Maria
    Bender, Sebastien
    Roussel, Murielle
    Jaccard, Arnaud
    Bridoux, Frank
    Sirac, Christophe
    BLOOD, 2021, 138
  • [3] Doxycycline Reduces Fibril Formation in a Transgenic Mouse Model of AL Amyloidosis
    Seldin, David C.
    Ward, Jennifer
    Ren, Ruiyi
    Toraldo, Gianluca
    SooHoo, Pamela T.
    Guan, Jian
    O'Hara, Carl
    Jasuja, Ravi
    Trinkaus-Randall, Vickery
    Liao, Ronglih
    Connors, Lawreen H.
    BLOOD, 2011, 118 (21) : 800 - 800
  • [4] Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis
    Ward, Jennifer Ellis
    Ren, Ruiyi
    Toraldo, Gianluca
    SooHoo, Pam
    Guan, Jian
    O'Hara, Carl
    Jasuja, Ravi
    Trinkaus-Randall, Vickery
    Liao, Ronglih
    Connors, Lawreen H.
    Seldin, David C.
    BLOOD, 2011, 118 (25) : 6610 - 6617
  • [5] Transgenic mouse model of AA amyloidosis
    Solomon, A
    Weiss, DT
    Schell, M
    Hrncic, R
    Murphy, CL
    Wall, J
    McGavin, MD
    Pan, HJ
    Kabalka, GW
    Paulus, MJ
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (04): : 1267 - 1272
  • [6] Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model
    Lifshitz, Veronica
    Weiss, Ronen
    Benromano, Tali
    Kfir, Einat
    Blumenfeld-Katzir, Tamar
    Tempel-Brami, Catherine
    Assaf, Yaniv
    Xia, Weiming
    Wyss-Coray, Tony
    Weiner, Howard L.
    Frenkel, Dan
    NEUROBIOLOGY OF AGING, 2012, 33 (02)
  • [7] A transgenic mouse model of human systemic amyloidosis
    Benson, M. D.
    Kalopissis, A. D.
    Charbert, M.
    Liepnieks, J. J.
    Kluve-Beckerman, B.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 46 - 46
  • [8] Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis
    Paris, D
    Patel, N
    DelleDonne, A
    Quadros, A
    Smeed, R
    Mullan, M
    NEUROSCIENCE LETTERS, 2004, 366 (01) : 80 - 85
  • [9] A transgenic mouse model mimicking human cardiac amyloidosis
    Fauvel, C.
    Mulder, P.
    Heron, C.
    Nicol, L.
    Brakenhielm, E.
    Bellien, J.
    Kalopissis, A.
    Bauer, F.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2953 - 2953
  • [10] Finally, a transgenic light chain amyloidosis mouse model
    Kelly, Jeffery W.
    BLOOD, 2011, 118 (25) : 6479 - 6480
12345